Tags: TLR agonists
               New Direct-Acting Antiviral Agents and Immunomodulators for Hepatitis B Virus Infection
               
               
Abstract: Chronic hepatitis B (CHB) affects over 350 million individuals worldwide and is the most common cause of liver cancer. In the United States, CHB […]
